Pharmafile Logo
Pharmafocus logo
Advanced Search

Research and Development

Showing 15 posts of 9607 posts found.

Contract research news in brief

March 27, 2012 Research and Development AMRI, Cetero, Kforce, Particle Sciences and QED Clinical Services, inVentiv Health

Cetero files for bankruptcy after FDA admonishments, AMRI shutters Hungarian facility and inVentiv Health buys Kforce; also updates from Particle …
News

HPI strengthens healthcare and pharma presence with new hire

March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing

HPI has strengthened its presence in the healthcare and pharma sectors with the appointment of Marianne MacDonell. She will head …
Appointment

UCB nominates new board members

March 26, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing UCB, board members

UCB has nominated Harriet Edelman and Charles-Antoine Janssen to become new members of UCB’s board of directors. The new nominations …
Appointment

Rare diseases – pharma’s new frontier

March 26, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Big Pharma, CAPS, McConaghie, rare diseases

The last ten years has seen our understanding of rare diseases move ahead rapidly, often thanks to greater understanding of …
Feature
Shire image

Shire signs CNS disorders deal with Heptares

March 23, 2012 Research and Development A2A, CNS, GPCR, Heptares, Shire

Shire is to develop and commercialise a novel adenosine A2A antagonist discovered by Heptares currently in pre-clinical development.UK-based Heptares discovers and …
News

Early-stage research gains another funding boost

March 23, 2012 Research and Development, Sales and Marketing GSK, Index Ventures, Janssen, R&D

GlaxoSmithKline and Janssen are among the key investors in a venture capital fund aimed solely at identifying promising pharma start-ups.  …
News
screen_shot_2012-03-22_at_11

Working Life: Mike Crooks, UK general manager, Astellas

March 22, 2012 Business Services, Manufacturing and Production, Medical Communications, Research and Development, Sales and Marketing Astellas Pharma, Mike Crooks, Working Life

 Mike Crooks became general manager of Astellas Pharma in December 2011. He joined Astellas in 2007 as marketing director, becoming …
Feature
GSK image

GSK selects Ulverston for biopharma manufacturing hub

March 22, 2012 Manufacturing and Production, Research and Development, Sales and Marketing Cameron, GSK, Ulverston, manufacturing

GlaxoSmithKline has announced the long-awaited decision on the location of its biopharmaceutical plant in the UK, with Ulverston in Cumbria …
News

Former Roche man Guido Magni joins Versant

March 22, 2012 Business Services, Manufacturing and Production, Research and Development, Sales and Marketing Versant, appointment, investment firm

Dr Guido Magni is joining US-based firm Versant Ventures as a venture partner to further strengthen the firm’s investment team …
Appointment
Abbott image

Abbott selects ‘AbbVie’ as new name for R&D firm

March 21, 2012 Research and Development, Sales and Marketing Abbott

Abbott has said its new R&D firm will be called AbbVie, and expects to launch the spin-off company at the …
News

British biotech industry gains £200m boost

March 21, 2012 Research and Development, Sales and Marketing GSK, Wellcome Trust, biotech, fund

The Wellcome Trust is to launch a £200 million business that will invest in emerging healthcare and life sciences firms. …
News
Merck image

Merck ends development on atrial fibrillation pill

March 20, 2012 Research and Development, Sales and Marketing Cardiome, Merck, atrial fibrillation

Merck will no longer help its partner Cardiome develop an oral formulation of the atrial fibrillation drug vernakalant. The pill …
News

UCB signs £3.6m research deal with Oxford University

March 20, 2012 Research and Development, Sales and Marketing Oxford University, UCB, collaboration, research

UCB Pharma and Oxford University have signed an R&D collaboration agreement covering immunology and neurology. The idea is to pool …
News
AstraZeneca image

AstraZeneca pulls depression drug, takes $50m hit

March 20, 2012 Research and Development, Sales and Marketing AstraZeneca, R&D, depression, failure, pipeline

AstraZeneca and partner Targacept will not file their depression drug TC-5214 for regulatory review. The decision comes after disappointing Phase …
News

AstraZeneca touting for business at partnering conference

March 19, 2012 Research and Development, Sales and Marketing AstraZeneca, Bio-Europe, R&D, partnering

AstraZeneca is marketing itself as a key partner for drug development deals, ahead of a European partnering conference.  The Bio-Europe …
News
The Gateway to Local Adoption Series

Latest content

Secarna appoints Jens Holstein and Richard Mark Engelhard to new Advisory Board

March 25, 2026

Roche adds 2,176 NVIDIA Blackwell GPUs to its hybrid-cloud AI factory

March 25, 2026

ReproNovo appoints Mark Altmeyer as Chairman of the Board

March 24, 2026

EndoCyclic New Drug application approved by US FDA for endometriosis treatment

March 24, 2026

Mestag Therapeutics appoints Lindsey Rolfe as Chief Medical Officer and Pascal Merchiers as Chief Development Officer

March 23, 2026